MISTIE INTRACEREBRAL HEMORRHAGE TRIAL

Does faster clot removal in ICH give better patient outcomes?

115 Sites to Qualify:
115
90 Sites to Activate:
77
500 Participants to Enroll:
407

The Transformation of Clinical Research at BIOS

Much has been written about the escalating costs, slowing cycle times, and long time-to-publication for clinical trials.[1][2] Despite significant effort to harmonize regulations, develop sophisticated data systems and rethink outmoded practices, transformation in clinical research has been much slower than in other industries.[3]

The first off-the-shelf electronic data capture (EDC) systems emerged in the late 1990’s. Despite demonstrated tangible benefits [4], it took more than 10 years before EDC was widely adopted in the pharmaceutical industry; adoption in academic trials has been even slower.[5]  On the site startup side, some 30% of pharmaceutical and medical device companies, as reported in a 2013 NextDocs survey, were still using paper-based files and only 24% were using a dedicated electronic trial master file (eTMF) system.[6] Adoption of centralized (risk-based) monitoring, adaptive designs and similar business and technological innovations has also been painfully slow.

Certainly, a number of factors come into play, but a core obstacle may be that, by definition, clinical trials involve large numbers of people — and people (or their institutions!) can be highly resistant to change. In an informal 2009 clinical site survey by ClinPage, 26% of 629 respondents, 71% being study coordinators, said EDC data were being initially entered from a paper CRF rather than direct data collection. This is surprisingly worse than the 21% in their earlier 2001 survey. Whether this reflects human cultural hesitation, growing institutional fears (over HIPPA, European Data Directive, etc.), or just the ever increasing complexity of studies, much of the value of an EDC system is lost if its implementation does little more than transfer the task of entering intermediary paper case forms (“data collection worksheets”) from the sponsor to the investigator.[7]

BIOS’ experience with the MISTIE clinical development program is a good example of how transformational technology and business process change can reduce time and cost while improving quality. But, more importantly, it serves as an example of how innovation, to be successful, must be implemented in the context of a well-designed plan executed by a skill project management team.

Continue reading
3912 Hits

Save the Date: Quarterly MISTIE III Safety Forum

Please save the date for our

Quarterly MISTIE III Safety Forum

To be held via webinar

Wednesday, September 16th, 1-2pm EDT

 

Registration link: https://attendee.gotowebinar.com/register/4448979556126173697

 

Agenda:

MISTIE III Surgical Summary and Lessons Learned

Heparin Use in MISTIE III

Click here for a video recording of the Safety Forum.

 

 

2627 Hits

Grandma Nicki

Grandma Nicki

We missed Nicki at our MISTIE team meeting this week, but it seems she had a good excuse! She is now a proud new grandmother of a beautiful 5.4 pound little girl named Lili who was born on July 8th.  Congratulations Nicki!

3176 Hits

Site Inservice Training Slides Available

Good news everyone! Inservice training slides are now available in the documents section under Training Files. These are specifically designed to give non-core team members at your site a quick but comprehensive overview of the trial. 

http://braininjuryoutcomes.com/mistie-documents/viewcategory/66 

2833 Hits

MISTIE-III Mobile App is Now Available on the iPhone and Android Devices!


The new MISTIE-III mobile application is now finished! It is currently available for download on the iPhone and Android devices and can also be accessed using this link: http://braininjuryoutcomes.com/mistie-mobile/web/mistie.php

 

    b2ap3_thumbnail_Screen-Shot-2014-12-02-at-12.08.59-PM.png                 b2ap3_thumbnail_SamJPEG.png

Continue reading
4118 Hits

Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
 
24-Hr: (410) 736-1368